Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,648.9
28.7 (1.10%)

 

  • STI Straits Times Index
    2,648.9
    28.7 (1.10%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,585.6
    -13.2 (-0.83%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,481.6
    3.7 (0.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,361.3
    -53.3 (-1.56%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,945.5
    358.5 (1.59%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,075.8
    -3.3 (-0.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,366.2M
  • Value: 1,138.6M
  • Rise: 196
  • Fall: 167
  • Unch: 447

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.176+0.007
IX Biopharma0.285-0.030
Biolidics0.435-0.085
Singapore-eDev0.091-0.011
Hyphens Pharma0.420-0.060
Clearbridge0.186-0.002
QT Vascular0.008-
Medtecs Intl0.645+0.010
Genting Sing0.785+0.010
Singtel2.540+0.020

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MATINAS BIOPHARMA HOLDINGS INC MATINAS BIOPHARMA HOLDINGS
Updated on 14 Jul 2020 (End of trading day)
Last (USD): 0.750 Change: +0.037 High: 0.750 Remarks: -
Change (%): +5.25 Low: 0.705
Open 0.720 Yesterday's Close 0.7125
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,770,638 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.19894 Trailing EPS (USD) e -0.20873 NAV (USD) b 0.8007
PE a - Trailing PE f - Price / NAV b 0.9366
Dividend (USD) d - Cash In Hand (USD) g 0.1112 Issued & Paid-up Shares c 198,873,000
Dividend Yield (%) d - Price / Cash In Hand g 6.744 Treasury Shares h -
Market Cap (M) 68.970 Enterprise Value (M) 5.727
Piotroski F Score 1 Exchange Code MTNB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 100.67 Free Float (%) 84.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Mar 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MATINAS BIOPHARMA HOLDINGS INC NYSE American 68.970 - - 0.9366 -
Industry Biotechnology NYSE American 118.650 - - 3.6871 -
Local Peer NANOVIRICIDES INC NYSE American 447.180 - - 31.2335 -
Local Peer CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL NYSE American 255.237 - - 50.4110 -
Local Peer IBIO INC NYSE American 215.340 - - 54.3326 -
Local Peer PFENEX INC NYSE American 185.409 175.228 - 2.2291 -
Local Peer CEL-SCI CORP NYSE American 129.397 - - 10.5988 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 111.796 - - 1.0498 -
Local Peer AIM IMMUNOTECH INC NYSE American 84.823 - - 2.4698 -
Local Peer 22ND CENTURY GROUP INC NYSE American 77.738 - - 1.3333 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 77.593 2.169 2.092 0.8951 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 72.155 - - 2.1550 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 62.905 - - -12.0516 -
Local Peer ORAGENICS INC NYSE American 45.381 - - 7.9124 -
Other Local Peers ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American)
Global Peer AMGEN INC NASDAQ 148,879.433 18.985 19.398 15.6963 2.304
Global Peer GILEAD SCIENCES INC NASDAQ 96,824.820 17.977 19.513 4.3878 3.295
Global Peer CSL ASX 130,461.899 48.627 45.037 15.0851 0.923
Global Peer VERTEX PHARMACEUTICAL NASDAQ 76,183.361 64.737 50.421 11.7901 -
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 72,152.463 34.102 31.656 5.9468 -
Global Peer ILLUMINA INC NASDAQ 55,308.750 55.198 58.714 11.9329 -
Global Peer BIOGEN INC NASDAQ 45,899.607 7.795 7.808 3.6582 -
Global Peer SEATTLE GENETICS INC NASDAQ 30,021.080 - - 17.0031 -
Global Peer MODERNA INC NASDAQ 29,177.353 - - 17.7816 -
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), WUXI BIO (HKEx), SINO BIOPHARM (HKEx), ALEXION PHARMACEUTICAL INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE (HKEx), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), Lonza (SGX), 3SBIO (HKEx), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), GENSCRIPT BIO (HKEx), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VIELA BIO INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), HAOHAI BIOTEC (HKEx), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), EDITAS MEDICINE INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), VERACYTE INC (NASDAQ), REGENXBIO INC (NASDAQ), NANTKWEST INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), VAXCYTE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), ESPERION THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ARVINAS INC (NASDAQ), MESOBLAST LTD (ASX), BEAM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), FRONTAGE (HKEx), NANOSTRING TECHNOLOGIES INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), COMPUGEN (NASDAQ), NKARTA INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), BIOXCEL THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), RETROPHIN INC (NASDAQ), ASCENTAGE-B (HKEx), PASSAGE BIO INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), KINTOR PHARMA-B (HKEx), PRECIGEN INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), IMMUNOGEN INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), IMMATICS N V (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), AKOUOS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NYSE), FREQUENCY THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), VANDA PHARMACE INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AGENUS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), AVROBIO INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ARDELYX INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ATHERSYS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), ASCLETIS-B (HKEx), VIKING THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), SINOMAB BIO-B (HKEx), PREVAIL THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), SINOVAC BIOTECH LTD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), XBIOTECH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), ESSEX BIO-TECH (HKEx), BRAINSTROM CELL THERAPEUTICS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), PDL BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), DPHARMA (Bursa), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEXTCURE INC (NASDAQ), EQUILLIUM INC (NASDAQ), TELIX PHARMACEUTIC (ASX), ADMA BIOLOGICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), VERASTEM INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ADURO BIOTECH INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), OTONOMY INC (NASDAQ), CHIMERIX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TREVENA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), ARAVIVE INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NEXT SCIENCE LTD (ASX), OUTLOOK THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), BELLUS HEALTH INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), INFLARX N V (NASDAQ), ORGENESIS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), NEUROBO PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), UNI-BIO GROUP (HKEx), SAVARA INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), IMUGENE LIMITED (ASX), AVEO PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), HEAT BIOLOGICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SESEN BIO INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), SYNLOGIC INC (NASDAQ), CURIS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), VASCULAR BIOGENICS LTD (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), IMMUTEP LTD (ASX), BIOTRON (ASX), INFINITY PHARMACEUTICALS INC (NASDAQ), MEMPHASYS LTD (ASX), SEELOS THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CT ENTERPRISE (HKEx), MIRAGEN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIOSINO BIO-TEC (HKEx), GENETIC TECHNOLOGIES (ASX), KAZIA THERAPEUTICS LIMITED (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), AIKIDO PHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), BIONOMICS LTD (ASX), ANTEOTECH LIMITED (ASX), EVOGENE LTD (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), Suntar Eco-City (SGX), OCUGEN INC (NASDAQ), REGENT PACIFIC (HKEx), ITERUM THERAPEUTICS PLC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), BIO-PATH HOLDINGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), PRECIPIO INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), REGENEUS LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), PATRYS LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), RHINOMED LIMITED (ASX), SENECA BIOPHARMA INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), XENETIC BIOSCIENCES INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), CRYOSITE (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), NANOLLOSE LTD (ASX), HAO WEN HLDGS (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.015
+2.03 %
10 Days --0.032
-4.10 %
20 Days --0.065
-7.99 %
Medium Term Return 3 Months -+0.020
+2.73 %
6 Months --0.650
-46.44 %
1 Year -+0.020
+2.73 %
Long Term Return 2 Years -+0.370
+97.34 %
3 Years --0.700
-48.28 %
Annualised Return Annualised --
-19.73 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.490 - 2.490 Change From 1 Year Low +0.260 % Change From 1 Year Low (%) +53.04
Change From 1 Year High -1.740 % Change From 1 Year High (%) -69.88
2 Years Range 0.345 - 2.490 Change From 2 Years Low +0.405 % Change From 2 Years Low (%) +117.36
Change From 2 Years High -1.740 % Change From 2 Years High (%) -69.88
5 Years Range 0.324 - 3.950 Change From 5 Years Low +0.426 % Change From 5 Years Low (%) +131.67
Change From 5 Years High -3.200 % Change From 5 Years High (%) -81.02
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. Its anti-fungal product candidate, MAT2203, delivers broad-spectrum fungicidal agent, amphotericin B, and is being developed to prevent invasive fungal infections in patients with acute lymphoblastic leukemia. The company was founded by Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Jul 2020 0.720 0.750 0.705 0.750 1,770,638 -
13 Jul 2020 0.720 0.734 0.680 0.713 2,583,624 -
10 Jul 2020 0.710 0.710 0.680 0.710 1,592,515 -
09 Jul 2020 0.760 0.760 0.700 0.704 1,629,757 -
08 Jul 2020 0.770 0.770 0.720 0.735 1,352,122 -
07 Jul 2020 0.785 0.785 0.751 0.760 1,218,339 -
06 Jul 2020 0.760 0.790 0.750 0.770 1,409,838 -
02 Jul 2020 0.790 0.790 0.764 0.770 1,272,109 -
01 Jul 2020 0.797 0.800 0.770 0.782 1,304,359 -
30 Jun 2020 0.810 0.810 0.760 0.773 1,595,765 -
29 Jun 2020 0.810 0.818 0.770 0.792 1,325,644 -
26 Jun 2020 0.840 0.840 0.780 0.792 1,836,617 -
25 Jun 2020 0.840 0.847 0.802 0.825 1,322,915 -
24 Jun 2020 0.880 0.890 0.819 0.830 1,692,639 -
23 Jun 2020 0.835 0.891 0.805 0.888 2,910,443 -
22 Jun 2020 0.840 0.840 0.790 0.799 1,448,995 -
19 Jun 2020 0.820 0.840 0.800 0.824 1,261,152 -
18 Jun 2020 0.810 0.820 0.790 0.812 891,301 -
17 Jun 2020 0.850 0.850 0.790 0.815 1,225,227 -
16 Jun 2020 0.860 0.860 0.818 0.831 1,095,195 -
15 Jun 2020 0.842 0.860 0.792 0.825 1,779,856 -
12 Jun 2020 0.870 0.870 0.780 0.819 1,391,898 -
Summary
Current 2 Weeks
(30 Jun 2020 to 14 Jul 2020)
0.810 0.810 0.680 0.750 15,729,066 -
Previous 2 Weeks
(16 Jun 2020 to 29 Jun 2020)
0.860 0.860 0.680 0.792 15,010,128 -
4 Weeks from
(18 May 2020 to 15 Jun 2020)
0.788 0.827 0.680 0.825 39,052,537 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.